Eleven Biotherapeutics (NASDAQ:EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced it will report fourth quarter and year ended December 31, 2014 financial results on Wednesday, March 4, 2015. Eleven's management team will host a conference call and audio webcast at 8:30 a.m. EST, on Wednesday, March 4, 2015 to discuss the financial results and recent business developments.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
